Pulmonary Hypertension

Fellowship Program at McMaster

Welcome to the Pulmonary Hypertension Fellowship at McMaster University!
Dr. Nathan Hambly, Fellowship Director
Dr. Nathan Hambly, Fellowship Director


Pulmonary hypertension (PH) is a serious and progressive lung disease, defined by an elevation of pulmonary artery pressure, and frequently complicated by right ventricular failure and premature death. Optimal management, including medical therapy, depends upon an accurate diagnosis, a dedicated team consisting of knowledgeable physicians and allied healthcare providers, and a familiarity with the available PAH-specific medications, their benefits, and side effects. Based on Canadian and international expert consensus, it is strongly recommended that PAH patients should be managed at PH centres with demonstrated expertise. As such, Health Canada mandates that PAH-targeted medications can only be prescribed from dedicated centres of excellence.

The McMaster University PH Program at St. Joseph’s Health Healthcare is a Nationally Recognized site of PH excellence. We review approximately 125 consultations annually and manage a prevalent population of 150 patients with Group 1 PAH and CTEPH. Given our location within the Firestone Institute for Respiratory Health, the emphasis is also applied to the evaluation and management of Group 3 PH and sarcoid-related PH. Focus is applied to both clinical excellence and the application of the clinical experience to innovative research projects utilizing both local and national registry data.

Certification Outcome

The successful completion of the fellowship will grant a Fellowship McMaster Certification.

Entry Requirements

The fellowship program is designed for current residents or recent graduates (list any prerequisite programs). Recent graduates are required to submit an application form and comply with McMaster University Postgraduate Medical Education requirements for residents and fellows.

Application Deadline

Yearly on November 30. Off-cycle training is accepted, please inquire about off-cycle training with the Fellowship Director.


Goals of Training

  • Develop competence in the diagnostic evaluation and classification of Pulmonary Hypertension.
  • Develop competence in the advanced management of Pulmonary Hypertension utilizing targeted PAH therapies.
  • Apply and integrate the clinical experience into transformative clinical research projects.

Length of Training

1 year


Funding for the PH fellowship will be flexible depending on the specific nature and training objectives of the fellowship candidate. Options include:

  • Sponsored International Medical Graduates
  • Independent grants funded through research grants or applications through our partners in the
    pharmaceutical industry
  • Self-Funded Clinical Fellow

Curriculum Highlights

Training will be delivered in the ambulatory setting with inpatient consultations as required. The main objective of the training is to provide clinical training in several overlapping areas of respiratory medicine. Points of emphasis will include:

  • A formal academic curriculum that consists of clinical sessions, lectures, journal clubs, group discussions, and clinical research and multidisciplinary clinical team meetings.
  • Clinical and research education in the setting of supervised research projects.

Supervision & Feedback

Evaluation of Fellow performance and educational initiative will be centred on:

  1. Completion of rotation-specific entrustable professional activities and milestones.
  2. Improving student performance using self-directed learning facilitated by quarterly self-assessment evaluations and the utilization of multi-source feedback surveys with an emphasis on non-medical expert CanMEDS roles.
  3. Implementation of a validated instrument to measure the perceived quality of instructional activities in the outpatient environment (see appendix).
  4. Standardized evaluations of learner skills in teaching during their presentations at the ILD-MDD and case-based discussions.
  5. The quality and number of presentations and peer-reviewed publications covering a breadth of clinical, medical education, and translational research projects.

Nathan Hambly

Medicine, Respirology
Nathan Hambly
Associate Professor
Interstitial Lung Disease Program Director

905-525-9140 ext. 36704

Medicine Specialties Central Fellowship Office

Placeholder portrait image for Medicine Specialties Central Fellowship Office


PGME Fellowship Office

Placeholder portrait image for PGME Fellowship Office

905-525-9140 ext. 26660

Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsaoda@mcmaster.ca.